Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Acta Oto-Laryngologica|January 15, 2016
Expression of MAGE-A1, -A9, -A11 in laryngeal squamous cell carcinoma and their prognostic significance: a retrospective clinical studyShenghui Liu, Meixiang Sang, Yuru Xu, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 4, 2015
Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patientsFei Liu, Lina Gu, Yu Cao, et al.Frontiers in Microbiology|January 9, 2023
The clinical characteristics and risk factors for severe COVID-19 in patients with COVID-19 and tuberculosis coinfectionYang Wang, Yanping Chen, Lina Gu, et al.American Journal of Otolaryngology|November 17, 2019
The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinomaShenghui Liu, Yan Zhao, Yuru Xu, et al.Human Pathology|August 15, 2018
Tumor necrosis factor α-induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapyJing Wang, Hongyu Gao, Guohui Liu, et al.The Journal of Physical Chemistry. B|February 8, 2024
Phase Change Study of a New Two-Phase Absorbent Based on DAPLina Gu, Xueyan Hou, Lijian Jin, et al.Frontiers in Psychiatry|March 27, 2026
Prevalence and clinical correlates of aggressive behavior in male inpatients with alcohol dependence during hospitalizationYang Liu, Wenzheng Li, Haining Yu, et al.BMC Cancer|February 10, 2025
Radiomics feature is a risk factor for locally advanced cervical cancer treated using concurrent chemoradiotherapy based on magnetic resonance imaging: a retrospective studyYuan Wang, Yanyan Yu, Lina Gu, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 14, 2014
NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinomaLina Gu, Bairong Xia, Lili Zhong, et al.Oncology Reports|May 19, 2023
Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptorYang Zheng, Meixiang Sang, Fei Liu, et al.Pageof 11